¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"oxygen dissociation curve"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • bimodal curve
    µÎ²À´ë±â°î¼±, ÀÌÁ¤Á¡°î¼±
  • binomial curve
    ÀÌÇ×°î¼±
  • boiling curve
    ²ú´ÂÁ¡°î¼±, ºñµî°î¼±
  • bone conduction curve
    »ÀÀüµµÃ»·Â°î¼±, °ñÀüµµÃ»·Â°î¼±
  • concentration-response curve
    ³óµµ¹ÝÀÀ°î¼±
  • concentration-time curve
    Ç÷Áß³óµµ°î¼±
  • cardiac function curve
    ½ÉÀå±â´É°î¼±
  • curve
    °î¼±
  • calibration curve
    ±³Á¤°î¼±, Ç¥ÁØÈ­°î¼±
  • demand curve
    ¼ö¿ä°î¼±
  • depth dose curve
    ½ÉºÎ¼±·®°î¼±
  • distribution curve
    ºÐÆ÷°î¼±
  • dose-response curve
    ¿ë·®¹ÝÀÀ°î¼±
  • extension curve
    ½ÅÀü°î¼±
  • elastic curve
    ź·Â°î¼±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • base curve
    ±âº»°î¼±
  • bimodal curve
    µÎ²À´ë±â°î¼±, ÀÌÁ¤Á¡°î¼±
  • binomial curve
    ÀÌÇ×°î¼±
  • boiling curve
    ²ú´ÂÁ¡°î¼±, ºñµî°î¼±
  • bone conduction curve
    »ÀÀüµµÃ»·Â°î¼±, °ñµµÃ»·Â°î¼±
  • curve
    °î¼±
  • calibration curve
    ±³Á¤°î¼±, Ç¥ÁØÈ­°î¼±
  • cardiac function curve
    ½ÉÀå±â´É°î¼±
  • concentration-response curve
    ³óµµ¹ÝÀÀ°î¼±
  • concentration-time curve
    Ç÷Áß³óµµ°î¼±
  • demand curve
    ¼ö¿ä°î¼±
  • depth dose curve
    ½ÉºÎ¼±·®°î¼±
  • distribution curve
    ºÐÆ÷°î¼±
  • dose-response curve
    ¿ë·®¹ÝÀÀ°î¼±
  • elastic curve
    ź·Â°î¼±
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • deficit oxygen
    »ê¼Ò°áÇÌ(Ë×ËÛ˭̰).
  • dissolved oxygen
    ¿ëÁ¸»ê¼Ò(éÁðíß«áÈ), ¿ëÇØ»ê¼Ò.
  • dissolved oxygen determination
    ¿ëÁ¸»ê¼Ò·®ÃøÁ¤.
  • free radical formation,oxygen derived
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, »ê¼Ò ±â¿ø¼º(ß«áÈ ÑÃê¹àõ)
  • free radical formation,oxygen toxicity
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, »ê¼Òµ¶¼º(ß«áÈÔ¸àõ)
  • heavy oxygen
    Áß»ê¼Ò(ñìß«áÈ).
  • hyperbaric oxygen
    °í¾Ð»ê¼Ò
  • hyperbaric oxygen therapy
    °í¾Ð»ê¼Ò¿ä¹ý
  • ideal alveolar oxygen tension
    ÀÌ»ó(Àû)ÆóÆ÷ »ê¼ÒÀå·Â(ìµßÌîÜøËøàß«áÈíåæ³).
  • inspired oxygen fraction
    Èí±â»ê¼ÒºÐÀ²
  • liquid oxygen
    ¾×ü»ê¼Ò(äûô÷ß«áÈ).
  • local oxygen deficiency
    ±¹¼Ò¼º »ê¼Ò°áÇÌÁõ (¡­àõß«áÈÌÀù¹ñø).
  • maximum oxygen consumption
    ÃÖ´ë»ê¼Ò¼Ò¸ð·®.
  • maximum oxygen debt
    ÃÖ´ë»ê¼ÒºÎä·®(õÌÓÞß«áÈݶóðåÖ).
  • mean venous oxygen content =MVO2
    Æò±ÕÁ¤¸ÆÇ÷»ê¼Ò·®(¡­ð¡Øæúìß«áÈåÖ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
GDS geriatric depression scale; Global Deterioration Scale; Gordon Diagnostic System [for attention diso...
H&D Hunter and Driffield [curve]
IRC inspiratory reserve capacity; instantaneous resonance curve; International Red Cross; International ...
IRD infantile Refsum syndrome; isorhythmic dissociation
IVPF isovolume pressure flow curve
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
AUC Area under the concentration curve
AUC Area-under-the-response-curve
AUC Areas under the ROC curve
CRC concentration response curve
FTC frequency tuning curve
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • H and D curve
    Ư¼º °î¼±
  • lateral occlusal curve
    Ãø¹æ ±³ÇÕ ¸¸°î
    ÀÚ¿¬Ä¡°¡ ÀÖ´Â ¾ÇÀ¸·Î¼­ ´ë¼Ò±¸Ä¡¸¦ º¸¸é, ±× Çù¼³ ¾çÂÊ ±³µÎ¸¦ ¿¬°áÇÑ ¸éÀº Æò¸é°ú ÀÏÄ¡ÇÏÁö ¾Ê´Â´Ù. Áï ±³ÇÕ Æò¸éÀ» ±âÁØÀ¸·Î ÇÏ¿© º¸¸é, »ó¾Ç¿¡¼­´Â Ä¡¾Æ Àüü°¡ ¿Ü¹æÀ¸·Î ÇâÇϰí, ÇùÃø ±³µÎ´Â ¼³Ãøº¸´Ù »ó¹æ¿¡ ÀÖ´Ù. ¹Ý¸é¿¡ ÇÏ¾Ç Ä¡¾Æ¿¡¼­´Â Ä¡¾Æ Àüü°¡ ³»¹æÀ¸·Î ÇâÇϰí, ÇùÃø ±³µÎ°¡ ¼³Ãø ±³µÎº¸´Ù »ó¹æ¿¡ À§Ä¡Çϰí Àִµ¥ ÀÌ °ü°è¸¦ Ãø¹æ ±³ÇÕ ¸¸°î ¶Ç´Â ±¸Ä¡ ±³µÎÀÇ ¼öÆòÂ÷¶ó°í ÇÑ´Ù.
  • mediolateral curve
    ³»¿ÜÃø ¸¸°î
  • Monson curve
    ¸ó½¼ ¸¸°î
  • normal curve
    Á¤»ó °î¼±, Á¤±Ô °î¼±
  • occlusal curve
    ±³ÇÕ ¸¸°î
    ±³ÇÕ¸éÀÌ ³õÀÌ°Ô µÇ´Â ÀüµÎ¸é°ú ½Ã»ó¸é »óÀÇ Ä¡¿­ÀÇ ¸¸°î.
  • orientation plate for lateral compensating curve
    Ãø¹æ ¸¸°î ±âÁØÆÇ
    ÃÑ ÀÇÄ¡ÀÇ ÀΰøÄ¡ ¹è¿­ÀÇ °æ¿ì ±³Çձ⠻󿡼­ Àû´çÇÑ Á¶Àý ¸¸°îÀ» ÁÙ ¶§ »ç¿ëÇÏ´Â ±âÁØÆÇ. MonsonÀº Á¶Àý ¸¸°îÀÇ ¹Ý°æÀ» 10§¯·Î Çϰí ÀÖ´Ù. ¾ç ÁßÀýÄ¡¿Í Á¦ 2´ë±¸Ä¡ ¿ø½É ÇùÃø ±³µÎ¸¸À» ±³ÇÕÁ¦»ó¸é¿¡ Á¢Ã˽Ã۰í
  • phase curve
    À§»ó °î¼±
  • quadratic curve
    ÀÌÂ÷ °î¼±
  • regression curve
    ȸ±Í °î¼±
  • sagittal curve of occlusion
    ±³ÇÕÀÇ ½Ã»ó ¸¸°î
  • sagittal occlusal curve
    ÀüÈÄ ±³ÇÕ ¸¸°î
    ÀÚ¿¬ Ä¡¿­¿¡¼­, °¢ Ä¡¾Æ´Â ÀüÈÄ ¹× Ãø¹æ¿¡ ¸¸°îÀ» º¸ÀÌ¸ç ¹è¿­ÇØ Àִµ¥ ±× Áß¿¡¼­ ½Ã»ó¸é»óÀ¸·Î º» »ó¾Ç Ä¡¾ÆÀÇ ±³µÎÁ¤À» ¿¬°áÇÑ °î¼±À» ¸»ÇÑ´Ù.
  • Scammon curve
    ½ºÄɸó °î¼±
  • tension-length curve
    Àå·Â ±æÀÌ °î¼±
  • tension-length diagram curve
    Àå·ÂÀåµµ °î¼±
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
oxygen effect Enhancement of radiosensitivity of cells in a high concentration of oxygen.
(05 Mar 2000)
oxygen electrode A sensitive method to detect oxygen consumption, involves a PTFE (Teflon) membrane.
(18 Nov 1997)
oxygen inhalation therapy Inhalation of oxygen aimed at restoring toward normal any pathophysiologic alterations of gas exchange in the cardiopulmonary system, as by the use of a respirator, nasal catheter, tent, chamber, or mask.
(12 Dec 1998)
oxygen isotopes Stable oxygen atoms that have the same atomic number as the element oxygen, but differ in atomic weight. O-17 and 18 are stable oxygen isotopes.
(12 Dec 1998)
oxygen poisoning A body disturbance resulting from breathing high partial pressures of oxygen; characterised by visual and hearing abnormalities, unusual fatigue while breathing, muscular twitching, anxiety, confusion, incoordination, and convulsions; although the mechanism for development of the condition is obscure, a disruption of enzymatic activity is likely, perhaps as a result of free radical formation.
Synonym: oxygen poisoning.
(05 Mar 2000)
oxygen radical <chemistry> Any oxygen species that carries an unpaired electron (except free oxygen).
Examples are the hydroxyl radical and the superoxide anion. These radicals are very powerful oxidizing agents and cause structural damage to proteins and nucleic acids. They mediate the damaging effects of ionising radiation.
(18 Nov 1997)
oxygen radioisotopes Unstable isotopes of oxygen that decay or disintegrate emitting radiation. O atoms with atomic weights 13, 14, 15, 19, and 20 are radioactive oxygen isotopes.
(12 Dec 1998)
oxygen tent A transparent enclosure, suspended over the bed and enclosing the patient, used to supply a high concentration of oxygen.
(05 Mar 2000)
oxygen therapy Treatment in which an increased concentration of oxygen is made available for breathing, through a nasal catheter, tent, chamber, or mask.
(05 Mar 2000)
oxygen toxicity A body disturbance resulting from breathing high partial pressures of oxygen; characterised by visual and hearing abnormalities, unusual fatigue while breathing, muscular twitching, anxiety, confusion, incoordination, and convulsions; although the mechanism for development of the condition is obscure, a disruption of enzymatic activity is likely, perhaps as a result of free radical formation.
Synonym: oxygen poisoning.
(05 Mar 2000)
oxygen utilization coefficient The extraction coefficient for oxygen in any given tissue.
(05 Mar 2000)
lactacid oxygen debt That part of an oxygen debt represented by the production of lactic acid by anaerobic glycolysis during exercise and, therefore, by the need to eliminate it by oxidative metabolism during recovery.
(05 Mar 2000)
fructosyl aminocaproate-oxygen oxidoreductase <enzyme> Catalyses conversion of amadori products to fructosamine; isolated from pseudomonas
Registry number: EC 1.5.3.-
Synonym: amadoriase, 1-deoxyfructosyl alkyl amino acid oxidase, fructosyl amino acid oxidase, faod enzyme
(26 Jun 1999)
active length-tension curve The relationship between active isometric tension and preload (rest length) for a contracting muscle.
(05 Mar 2000)
alignment curve The line passing through the centre of the teeth laterally in the direction of the curve of the dental arch.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á